ANATARA LIFESCIENCES LTD - Announcements

0.00%

0.8¢

Market Cap $1.708M

Healthcare Biotechnology

Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is... Anatara Lifesciences Ltd is an Australia-based life sciences company. The Company is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.More

Announcements

Filter Results

All Price Sensitive Only

ANR	GaRP Clinical Trial AGM Presentation	PRICE SENSITIVE	10/11/23	1.12MB	Share
ANR	AGM Chair Address	PRICE SENSITIVE	10/11/23	161.46KB	Share
ANR	Notification of cessation of securities - ANR		10/11/23	21.74KB	Share
ANR	Cleansing Notice		06/11/23	216.39KB	Share
ANR	Letter to Optionholders		03/11/23	128.39KB	Share
ANR	Proposed issue of securities - ANR		03/11/23	30.73KB	Share
ANR	Cleansing Notice	PRICE SENSITIVE	03/11/23	177.93KB	Share
ANR	Anatara launches a partially underwritten Entitlement Offer	PRICE SENSITIVE	03/11/23	275.53KB	Share
ANR	Trading Halt	PRICE SENSITIVE	01/11/23	217.82KB	Share
ANR	Appendix 4C & Q1 FY24 Activities Report	PRICE SENSITIVE	31/10/23	621.82KB	Share
ANR	Webinar Investor Presentation	PRICE SENSITIVE	19/10/23	4.5MB	Share
ANR	IBS Trial Results Webinar and QA		17/10/23	217.31KB	Share
ANR	Anatara IBS trial positive secondary endpoint data analysis	PRICE SENSITIVE	17/10/23	451.5KB	Share
ANR	Appendix 4G and Corporate Governance Statement		16/10/23	533.89KB	Share
ANR	Annual Report to shareholders		16/10/23	1.79MB	Share
ANR	Trading Halt	PRICE SENSITIVE	16/10/23	530.43KB	Share
ANR	Notice of Annual General Meeting/Proxy Form		09/10/23	445.36KB	Share
ANR	Final Director's Interest Notice		02/10/23	189.07KB	Share
ANR	Initial Director's Interest Notice		02/10/23	148.21KB	Share
ANR	Anatara Board Changes		02/10/23	205.93KB	Share
ANR	ANR announces Positive Results from Stage 1 of IBS trial	PRICE SENSITIVE	28/09/23	373.51KB	Share
ANR	Trading Halt	PRICE SENSITIVE	26/09/23	527.46KB	Share
ANR	Pause in Trading	PRICE SENSITIVE	26/09/23	116.24KB	Share
ANR	Anatara Annual General Meeting & Director Nominations		19/09/23	189.66KB	Share
ANR	IBS clinical trial Stage 1 patients finalised	PRICE SENSITIVE	31/08/23	336.59KB	Share
ANR	Appendix 4E & Audited Financial Statements 30 June 2023	PRICE SENSITIVE	24/08/23	761.64KB	Share
ANR	$923,235 in R&D tax incentive received	PRICE SENSITIVE	14/08/23	180.46KB	Share
ANR	Notification regarding unquoted securities - ANR		01/08/23	25.34KB	Share
ANR	Appendix 4C & Q4 FY23 Activities Report	PRICE SENSITIVE	31/07/23	497.72KB	Share
ANR	Anatara Update on GaRP Irritable Bowel Syndrome Trial	PRICE SENSITIVE	06/06/23	327.06KB	Share
ANR	Anatara Investor Presentation		08/05/23	2.26MB	Share
ANR	Registered Office Change		20/04/23	147.74KB	Share
ANR	Appendix 4C & Q3 FY23 Activities Report	PRICE SENSITIVE	20/04/23	492.13KB	Share
ANR	Change in substantial holding		28/03/23	1.58MB	Share
ANR	Anatara Company Update	PRICE SENSITIVE	10/03/23	281.34KB	Share
ANR	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/23	348.26KB	Share
ANR	Notification regarding unquoted securities - ANR		21/02/23	23.7KB	Share
ANR	Application for quotation of securities - ANR		21/02/23	24.95KB	Share
ANR	Placement of Shortfall from Entitlement Offer	PRICE SENSITIVE	21/02/23	170.37KB	Share
ANR	Application for quotation of securities - ANR		30/01/23	24.99KB	Share
ANR	Notification of cessation of securities - ANR		19/01/23	21.72KB	Share
ANR	Revised Appendix 4C	PRICE SENSITIVE	13/01/23	380.13KB	Share
ANR	Appendix 4C & Q2 FY23 Activities Report	PRICE SENSITIVE	12/01/23	490.8KB	Share
ANR	Change of Director's Interest Notice		20/12/22	415.33KB	Share
ANR	Notification regarding unquoted securities - ANR		20/12/22	23.69KB	Share
ANR	Notification regarding unquoted securities - ANR		19/12/22	23.8KB	Share
ANR	Cleansing Notice		16/12/22	169.07KB	Share
ANR	Application for quotation of securities - ANR		16/12/22	24.89KB	Share
ANR	Change of Director's Interest Notice		14/12/22	409.46KB	Share
ANR	Notification of cessation of securities - ANR		12/12/22	21.71KB	Share
ANR	Notification of cessation of securities - ANR		12/12/22	21.7KB	Share
ANR	Results of Meeting		12/12/22	243.32KB	Share
ANR	Initial Director's Interest Notice		07/12/22	140.71KB	Share
ANR	Final Director's Interest Notice		07/12/22	189.61KB	Share
ANR	Board Changes		07/12/22	214.84KB	Share
ANR	Change of Director's Interest Notice		30/11/22	214.93KB	Share
ANR	Notification regarding unquoted securities - ANR		28/11/22	23.73KB	Share
ANR	Application for quotation of securities - ANR		28/11/22	24.63KB	Share
ANR	Completion of Non-renounceable Entitlement Offer and Shortfa	PRICE SENSITIVE	25/11/22	141.11KB	Share
ANR	Results of Meeting		11/11/22	240.2KB	Share
ANR	Chairman's Address to Shareholders		11/11/22	288.79KB	Share
ANR	AGM Clinical Trial Presentation		11/11/22	754.42KB	Share
ANR	Notice of General Meeting/Proxy Form		10/11/22	443.96KB	Share
ANR	Change in substantial holding - Tiga Trading Pty Ltd		31/10/22	184.44KB	Share
ANR	Change in substantial holding from TEK		31/10/22	207.8KB	Share
ANR	Entitlement Offer Letter to Shareholders		31/10/22	1.79MB	Share
ANR	Cleansing Notice		28/10/22	169.16KB	Share
ANR	Application for quotation of securities - ANR		28/10/22	25KB	Share
ANR	Appendix 4C & Q1 FY23 Activities Report	PRICE SENSITIVE	28/10/22	517.85KB	Share
ANR	Proposed issue of securities - ANR		21/10/22	26.94KB	Share
ANR	Proposed issue of securities - ANR		21/10/22	30.38KB	Share
ANR	Proposed issue of securities - ANR		21/10/22	33.9KB	Share
ANR	Entitlement Offer Prospectus	PRICE SENSITIVE	21/10/22	521.13KB	Share
ANR	Placement and Entitlement Offer	PRICE SENSITIVE	21/10/22	260.74KB	Share
ANR	Trading Halt	PRICE SENSITIVE	19/10/22	596.01KB	Share
ANR	Annual Report to shareholders		14/10/22	3.19MB	Share
ANR	Appendix 4G and Corporate Governance Statement		14/10/22	525.21KB	Share
ANR	Anatara Investor Presentation	PRICE SENSITIVE	13/10/22	2.15MB	Share
ANR	Notice of Annual General Meeting/Proxy Form		10/10/22	395.4KB	Share
ANR	R&D Tax Refund Received		05/10/22	174.46KB	Share
ANR	3FDC Clinical Trial update	PRICE SENSITIVE	03/10/22	204.51KB	Share
ANR	Annual General Meeting & Director Nominations		03/10/22	175.88KB	Share
ANR	Notification regarding unquoted securities - ANR		01/09/22	25.91KB	Share
ANR	Appendix 4E & Audited Financial Report 30 June 2022	PRICE SENSITIVE	29/08/22	596.87KB	Share
ANR	Operational Update	PRICE SENSITIVE	11/08/22	411.98KB	Share
ANR	Q4 FY22 Activities Report	PRICE SENSITIVE	01/08/22	379.53KB	Share
ANR	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	184.85KB	Share
ANR	Notification of cessation of securities - ANR		25/07/22	21.7KB	Share
ANR	Notification of cessation of securities - ANR		25/07/22	21.63KB	Share
ANR	Notification of cessation of securities - ANR		25/07/22	21.63KB	Share
ANR	Notification of cessation of securities - ANR		25/07/22	21.7KB	Share
ANR	Clinical Trial and Operational Update		22/06/22	329.78KB	Share
ANR	Clinical Trial and Operational Update	PRICE SENSITIVE	20/05/22	237.02KB	Share
ANR	Anatara Lifesciences announces leadership change	PRICE SENSITIVE	05/05/22	231.72KB	Share
ANR	Appendix 4C and Q3 FY22 Activities Report	PRICE SENSITIVE	29/04/22	455.76KB	Share
ANR	Clinical Trials Update	PRICE SENSITIVE	31/03/22	217.17KB	Share
ANR	Half Year Accounts	PRICE SENSITIVE	24/02/22	423.02KB	Share
ANR	Clinical Trials Update	PRICE SENSITIVE	17/02/22	206.65KB	Share
ANR	Appendix 4C and Q2 FY22 Activities Report	PRICE SENSITIVE	28/01/22	478.5KB	Share
ANR	Appendix 4C and Q2 FY22 Activities Report	PRICE SENSITIVE	27/01/22	371.97KB	Share

ANR GaRP Clinical Trial AGM Presentation
10/11/23	PRICE SENSITIVE	1.12MB	Share
ANR AGM Chair Address
10/11/23	PRICE SENSITIVE	161.46KB	Share
ANR Notification of cessation of securities - ANR
10/11/23		21.74KB	Share
ANR Cleansing Notice
06/11/23		216.39KB	Share
ANR Letter to Optionholders
03/11/23		128.39KB	Share
ANR Proposed issue of securities - ANR
03/11/23		30.73KB	Share
ANR Cleansing Notice
03/11/23	PRICE SENSITIVE	177.93KB	Share
ANR Anatara launches a partially underwritten Entitlement Offer
03/11/23	PRICE SENSITIVE	275.53KB	Share
ANR Trading Halt
01/11/23	PRICE SENSITIVE	217.82KB	Share
ANR Appendix 4C & Q1 FY24 Activities Report
31/10/23	PRICE SENSITIVE	621.82KB	Share
ANR Webinar Investor Presentation
19/10/23	PRICE SENSITIVE	4.5MB	Share
ANR IBS Trial Results Webinar and QA
17/10/23		217.31KB	Share
ANR Anatara IBS trial positive secondary endpoint data analysis
17/10/23	PRICE SENSITIVE	451.5KB	Share
ANR Appendix 4G and Corporate Governance Statement
16/10/23		533.89KB	Share
ANR Annual Report to shareholders
16/10/23		1.79MB	Share
ANR Trading Halt
16/10/23	PRICE SENSITIVE	530.43KB	Share
ANR Notice of Annual General Meeting/Proxy Form
09/10/23		445.36KB	Share
ANR Final Director's Interest Notice
02/10/23		189.07KB	Share
ANR Initial Director's Interest Notice
02/10/23		148.21KB	Share
ANR Anatara Board Changes
02/10/23		205.93KB	Share
ANR ANR announces Positive Results from Stage 1 of IBS trial
28/09/23	PRICE SENSITIVE	373.51KB	Share
ANR Trading Halt
26/09/23	PRICE SENSITIVE	527.46KB	Share
ANR Pause in Trading
26/09/23	PRICE SENSITIVE	116.24KB	Share
ANR Anatara Annual General Meeting & Director Nominations
19/09/23		189.66KB	Share
ANR IBS clinical trial Stage 1 patients finalised
31/08/23	PRICE SENSITIVE	336.59KB	Share
ANR Appendix 4E & Audited Financial Statements 30 June 2023
24/08/23	PRICE SENSITIVE	761.64KB	Share
ANR $923,235 in R&D tax incentive received
14/08/23	PRICE SENSITIVE	180.46KB	Share
ANR Notification regarding unquoted securities - ANR
01/08/23		25.34KB	Share
ANR Appendix 4C & Q4 FY23 Activities Report
31/07/23	PRICE SENSITIVE	497.72KB	Share
ANR Anatara Update on GaRP Irritable Bowel Syndrome Trial
06/06/23	PRICE SENSITIVE	327.06KB	Share
ANR Anatara Investor Presentation
08/05/23		2.26MB	Share
ANR Registered Office Change
20/04/23		147.74KB	Share
ANR Appendix 4C & Q3 FY23 Activities Report
20/04/23	PRICE SENSITIVE	492.13KB	Share
ANR Change in substantial holding
28/03/23		1.58MB	Share
ANR Anatara Company Update
10/03/23	PRICE SENSITIVE	281.34KB	Share
ANR Half Yearly Report and Accounts
24/02/23	PRICE SENSITIVE	348.26KB	Share
ANR Notification regarding unquoted securities - ANR
21/02/23		23.7KB	Share
ANR Application for quotation of securities - ANR
21/02/23		24.95KB	Share
ANR Placement of Shortfall from Entitlement Offer
21/02/23	PRICE SENSITIVE	170.37KB	Share
ANR Application for quotation of securities - ANR
30/01/23		24.99KB	Share
ANR Notification of cessation of securities - ANR
19/01/23		21.72KB	Share
ANR Revised Appendix 4C
13/01/23	PRICE SENSITIVE	380.13KB	Share
ANR Appendix 4C & Q2 FY23 Activities Report
12/01/23	PRICE SENSITIVE	490.8KB	Share
ANR Change of Director's Interest Notice
20/12/22		415.33KB	Share
ANR Notification regarding unquoted securities - ANR
20/12/22		23.69KB	Share
ANR Notification regarding unquoted securities - ANR
19/12/22		23.8KB	Share
ANR Cleansing Notice
16/12/22		169.07KB	Share
ANR Application for quotation of securities - ANR
16/12/22		24.89KB	Share
ANR Change of Director's Interest Notice
14/12/22		409.46KB	Share
ANR Notification of cessation of securities - ANR
12/12/22		21.71KB	Share
ANR Notification of cessation of securities - ANR
12/12/22		21.7KB	Share
ANR Results of Meeting
12/12/22		243.32KB	Share
ANR Initial Director's Interest Notice
07/12/22		140.71KB	Share
ANR Final Director's Interest Notice
07/12/22		189.61KB	Share
ANR Board Changes
07/12/22		214.84KB	Share
ANR Change of Director's Interest Notice
30/11/22		214.93KB	Share
ANR Notification regarding unquoted securities - ANR
28/11/22		23.73KB	Share
ANR Application for quotation of securities - ANR
28/11/22		24.63KB	Share
ANR Completion of Non-renounceable Entitlement Offer and Shortfa
25/11/22	PRICE SENSITIVE	141.11KB	Share
ANR Results of Meeting
11/11/22		240.2KB	Share
ANR Chairman's Address to Shareholders
11/11/22		288.79KB	Share
ANR AGM Clinical Trial Presentation
11/11/22		754.42KB	Share
ANR Notice of General Meeting/Proxy Form
10/11/22		443.96KB	Share
ANR Change in substantial holding - Tiga Trading Pty Ltd
31/10/22		184.44KB	Share
ANR Change in substantial holding from TEK
31/10/22		207.8KB	Share
ANR Entitlement Offer Letter to Shareholders
31/10/22		1.79MB	Share
ANR Cleansing Notice
28/10/22		169.16KB	Share
ANR Application for quotation of securities - ANR
28/10/22		25KB	Share
ANR Appendix 4C & Q1 FY23 Activities Report
28/10/22	PRICE SENSITIVE	517.85KB	Share
ANR Proposed issue of securities - ANR
21/10/22		26.94KB	Share
ANR Proposed issue of securities - ANR
21/10/22		30.38KB	Share
ANR Proposed issue of securities - ANR
21/10/22		33.9KB	Share
ANR Entitlement Offer Prospectus
21/10/22	PRICE SENSITIVE	521.13KB	Share
ANR Placement and Entitlement Offer
21/10/22	PRICE SENSITIVE	260.74KB	Share
ANR Trading Halt
19/10/22	PRICE SENSITIVE	596.01KB	Share
ANR Annual Report to shareholders
14/10/22		3.19MB	Share
ANR Appendix 4G and Corporate Governance Statement
14/10/22		525.21KB	Share
ANR Anatara Investor Presentation
13/10/22	PRICE SENSITIVE	2.15MB	Share
ANR Notice of Annual General Meeting/Proxy Form
10/10/22		395.4KB	Share
ANR R&D Tax Refund Received
05/10/22		174.46KB	Share
ANR 3FDC Clinical Trial update
03/10/22	PRICE SENSITIVE	204.51KB	Share
ANR Annual General Meeting & Director Nominations
03/10/22		175.88KB	Share
ANR Notification regarding unquoted securities - ANR
01/09/22		25.91KB	Share
ANR Appendix 4E & Audited Financial Report 30 June 2022
29/08/22	PRICE SENSITIVE	596.87KB	Share
ANR Operational Update
11/08/22	PRICE SENSITIVE	411.98KB	Share
ANR Q4 FY22 Activities Report
01/08/22	PRICE SENSITIVE	379.53KB	Share
ANR Quarterly Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	184.85KB	Share
ANR Notification of cessation of securities - ANR
25/07/22		21.7KB	Share
ANR Notification of cessation of securities - ANR
25/07/22		21.63KB	Share
ANR Notification of cessation of securities - ANR
25/07/22		21.63KB	Share
ANR Notification of cessation of securities - ANR
25/07/22		21.7KB	Share
ANR Clinical Trial and Operational Update
22/06/22		329.78KB	Share
ANR Clinical Trial and Operational Update
20/05/22	PRICE SENSITIVE	237.02KB	Share
ANR Anatara Lifesciences announces leadership change
05/05/22	PRICE SENSITIVE	231.72KB	Share
ANR Appendix 4C and Q3 FY22 Activities Report
29/04/22	PRICE SENSITIVE	455.76KB	Share
ANR Clinical Trials Update
31/03/22	PRICE SENSITIVE	217.17KB	Share
ANR Half Year Accounts
24/02/22	PRICE SENSITIVE	423.02KB	Share
ANR Clinical Trials Update
17/02/22	PRICE SENSITIVE	206.65KB	Share
ANR Appendix 4C and Q2 FY22 Activities Report
28/01/22	PRICE SENSITIVE	478.5KB	Share
ANR Appendix 4C and Q2 FY22 Activities Report
27/01/22	PRICE SENSITIVE	371.97KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $1.708M

Open	High	Low	Value	Volume
0.8¢	0.8¢	0.8¢	$1.84K	230.0K

Buyers (Bids)

No.	Vol.	Price($)
1	8893	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	908675	3

View Market Depth

No.	Vol.	Price($)
1	8893	0.008
6	1101919	0.007
9	2276169	0.006
10	3812000	0.005
6	3500052	0.004

Price($)	Vol.	No.
0.009	908675	3
0.010	1502600	4
0.011	520150	2
0.012	755000	2
0.013	300000	1

Last trade - 15.55pm 04/09/2025 (20 minute delay)

ANR (ASX) Chart

ANATARA LIFESCIENCES LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories